TFS Capital’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-23,493
Closed -$909K 785
2016
Q4
$909K Buy
+23,493
New +$909K 0.24% 149
2014
Q4
Sell
-24,826
Closed -$389K 1095
2014
Q3
$389K Buy
+24,826
New +$389K 0.03% 672
2014
Q2
Sell
-10,131
Closed -$163K 1278
2014
Q1
$163K Buy
+10,131
New +$163K 0.01% 1230
2013
Q3
Sell
-61,438
Closed -$822K 1560
2013
Q2
$822K Buy
+61,438
New +$822K 0.03% 695